Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) Operating Expenses (2016 - 2025)

INVO Fertility (IVF) has disclosed Operating Expenses for 15 consecutive years, with $3.4 million as the latest value for Q3 2025.

  • Quarterly Operating Expenses rose 24.11% to $3.4 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $32.1 million through Sep 2025, up 159.25% year-over-year, with the annual reading at $14.7 million for FY2024, 49.75% up from the prior year.
  • Operating Expenses for Q3 2025 was $3.4 million at INVO Fertility, down from $4.9 million in the prior quarter.
  • The five-year high for Operating Expenses was $18.7 million in Q1 2025, with the low at $1.9 million in Q3 2023.
  • Average Operating Expenses over 5 years is $3.8 million, with a median of $2.8 million recorded in 2022.
  • The sharpest move saw Operating Expenses crashed 32.58% in 2023, then soared 507.74% in 2025.
  • Over 5 years, Operating Expenses stood at $2.5 million in 2021, then grew by 19.98% to $3.0 million in 2022, then dropped by 3.54% to $2.9 million in 2023, then surged by 78.19% to $5.2 million in 2024, then plummeted by 34.13% to $3.4 million in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $3.4 million, $4.9 million, and $18.7 million for Q3 2025, Q2 2025, and Q1 2025 respectively.